Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Invitation Accepted: Biopharma Leaders Will Testify At Senate Hearing On Pricing

08 Feb 2019

• By Cathy Kelly

WASHINGTON - JULY 18: A sign at the entrance to a Senate Finance Committee hearing room in Washington, DC on July 18, 2017. The United States Senate is the upper chamber of the United States Congress.

Related Content

Brands Push Back Against REMS Reform, Call Problem Small With Burdensome Fixes

19 Jul 2017

Sen. Grassley To Be "More Insistent" About Drug Firms' Testimony At Future Hearings

30 Jan 2019

340B Legislative Reforms: Where Do We Go From Here?

19 Jun 2018

DTC Ad Proposal: Biopharma, Advertisers Marshall Legal Arguments In Opposition

19 Dec 2018

HHS Rebate Plan A Leap Of Faith? Lower Costs Hinge On Drug Firm, Plan Response

02 Feb 2019

Trulicity DTC Ads Reference Lilly Website For List Price, Cost Sharing Info

11 Jan 2019

Biosimilar Humira Blocked Until 2023, But Time Could Clear Commercial Path

28 Sep 2017

Related Companies

Pfizer Inc.

AstraZeneca PLC

Sanofi

Johnson & Johnson

Bristol Myers Squibb Company

Merck & Co., Inc.

AbbVie Inc.

Sanofi

Additional Topics

United States Pricing Debate Legislation Reimbursement Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.